Literature DB >> 10855048

Neuromotor development and language processing in developmental dyspraxia: a follow-up case study.

M T Le Normand1, L Vaivre-Douret, C Payan, H Cohen.   

Abstract

A longitudinal study of a child (MV) with developmental verbal dyspraxia was conducted to determine to what extent language development and motor performance in this clinical diagnosis followed a similar course of maturation. Patient MV was observed for two years from the age of 5 years and 6 months. Initially, this young patient exhibited unintelligible and atypical speech production (multiword utterances without consonants), delay in balance and coordination, and impairments in rhythmic tasks; but she was otherwise developing normally with no intellectual impairment or behavioral disorder. MRI scans showed moderately enlarged ventricles, a thin, incompletely myelinated corpus callosum and intact basal ganglia. Two years later, MV's performance was nearly normal only in comprehension aspects of language. In contrast, production aspects of language and speech and neuromotor development showed very little improvement after two years. These observations first suggest that development of receptive and expressive domains within language may be asynchronous, and that the progression of motor control of language appears to follow a parallel course to neuromotor development.

Entities:  

Mesh:

Year:  2000        PMID: 10855048     DOI: 10.1076/1380-3395(200006)22:3;1-V;FT408

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  2 in total

1.  Consonant and vowel articulation accuracy in younger and middle-aged Spanish healthy adults.

Authors:  Ignacio Moreno-Torres; Enrique Nava
Journal:  PLoS One       Date:  2020-11-09       Impact factor: 3.240

2.  Modelling speech motor programming and apraxia of speech in the DIVA/GODIVA neurocomputational framework.

Authors:  Hilary E Miller; Frank H Guenther
Journal:  Aphasiology       Date:  2020-05-18       Impact factor: 2.773

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.